Try Alerts Free   |   Login
Health Care › Services-Medical Laboratories

Biocept (BIOC) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 32 quarters since 2012. Compare with BIOC stock chart to see long term trends.

BIOC stock compared to

BIOC Income Statement

Revenue, Net:18511234
Revenue Per Share:1.56
Cost of Goods & Services Sold:10012661
Selling, General & Admin Expense:2166635
Research & Development Expense:1231145
Total Operating Expenses:16544514
Operating Income:1902071
Net Income:1902071
Earnings Per Share, Basic:0.53
Shares Outstanding, Basic Avg:11845255

BIOC Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:245440
Change in Accounts Receiveable:6190286
Net Cash from Operations:-1102999
Net Cash from Financing Activities:-584517
Property, Plant & Equipment Purchases:802483
Net Cash from Investing Activities:-802483
Net Change in Cash & Equivalents:-2489999

BIOC Balance Sheet

Cash and Cash Equivalents:14367942
Accounts Receivable, Net:14144911
Total Current Assets:32594004
Property, Plant & Equipment, Net:2317616
Total Assets:47451586
Accounts Payable:8364858
Total Short-Term Liabilities:12494253
Total Liabilities:23759164

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Vanguard Group Inc
654,603 sh
-5,823,014 sh
Blackrock Inc.
191,630 sh
-2,304,316 sh
Northern Trust Corp
27,663 sh
-250,542 sh
Ameriprise Financial Inc
15,805 sh
15,805 sh
Renaissance Technologies LLC
10,870 sh
-3,785,580 sh
Royal Bank Of Canada
757 sh
-34,296 sh
Morgan Stanley
100 sh
100 sh
Proequities, Inc.
0 sh

Data imported from Biocept Inc SEC filings. Check original filings before making any investment decision.